Authors: Dorr, R Karanes, C Spier, C Grogan, T Greer, J Moore, J Weinberger, B Schiller, G Pearce, T Litchman, M Dalton, W Roe, D List, AF

Citation: R. Dorr et al., Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia, J CL ONCOL, 19(6), 2001, pp. 1589-1599

Authors: Coppola, D Schreiber, RH Mora, L Dalton, W Karl, RC

Citation: D. Coppola et al., Significance of Fas and retinoblastoma protein expression during the progression of Barrett's metaplasia to adenocarcinoma, ANN SURG O, 6(3), 1999, pp. 298-304

Authors: Niu, GL Heller, R Catlett-Falcone, R Coppola, D Jaroszeski, M Dalton, W Jove, R Yu, H

Citation: Gl. Niu et al., Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo, CANCER RES, 59(20), 1999, pp. 5059-5063

Authors: Ruetz, S Brault, M Dalton, W Gros, P

Citation: S. Ruetz et al., Functional interactions between synthetic alkyl phospholipids and the ABC transporters P-glycoprotein, Ste-6, MRP, and Pgh-1 (vol 36, pg 8180, 1997), BIOCHEM, 38(9), 1999, pp. 2860-2860